TrialInternational journal of clinical oncology2019

Palbociclib in combination with letrozole in patients with estrogen receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer: PALOMA-2 subgroup analysis of Japanese patients.

Hirofumi Mukai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.